Process Development Intern, PharmD and Master’s Students jobs in United States
cer-icon
Apply on Employer Site
company-logo

Alexion Pharmaceuticals, Inc. · 1 day ago

Process Development Intern, PharmD and Master’s Students

positionSanta Monica, California, United States of America
timeInternship
remoteOnsite
seniorityIntern
money$41.50/hr - $48/hr
workcardStart in 2026 Spring

Alexion Pharmaceuticals, Inc. is seeking PharmD and Master’s level students for internship roles in process development. The interns will participate in laboratory activities, evaluate data, and present results during a 12-week internship in Santa Monica, CA.

BiotechnologyHealth CareMedicalTherapeutics
check
Comp. & BenefitsbadNo H1Bnote

Responsibilities

Participate in process development workflows
Execute laboratory activities
Evaluate data and presentation of results

Qualification

Wet lab techniquesTechnical writingMicrosoft ExcelBasic statisticsBasic immunology concepts

Required

PharmD and Master's level students majoring in Biology, Biochemical Engineering, Biomedical Engineering, Biotechnology or a related discipline. Candidates must have an expected graduation date after August 2026
Experience with wet lab techniques such as cell culture and pipetting required
Proficiency in Microsoft Excel and basic statistics required
Technical writing experience required
Ability to report onsite to Santa Monica, CA 4-5 days per week. This role will not provide relocation assistance
US Work Authorization is required at time of application
This role will not be providing OPT support

Preferred

Understanding of basic immunology concepts preferred

Benefits

Short-term incentive bonus opportunity
Equity-based long-term incentive program (salaried roles)
Retirement contribution (hourly roles)
Commission payment eligibility (sales roles)
Qualified retirement program [401(k) plan]
Paid vacation and holidays
Paid leaves
Health benefits including medical, prescription drug, dental, and vision coverage

Company

Alexion Pharmaceuticals, Inc.

twittertwittertwitter
Glassdoor3.9
company-logo
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.
dateFounded in 1992
location
Boston, Massachusetts, USA
people-size1001-5000 employees
web-link
https://alexion.com

Funding

Current Stage
Public Company
Total Funding
$5.8M
2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO

Leadership Team

leader-logo
Frederic Chereau
SVP, Strategy and Business Development
linkedin
leader-logo
Imran Shakur
Director, IRT and Technology Lead
linkedin

Recent News

bloomberglaw.com
AstraZeneca Unit Gets Partial Win in Soliris Drug Monopoly Case
2025-12-20
Business Wire
Complement C5 Inhibitors & C5 Receptor Antagonists Pipeline and Competitive Intelligence Report 2025 - ResearchAndMarkets.com
2025-12-01
EuropaWire
AstraZeneca Secures FDA Approval for Koselugo to Treat Adults with NF1 Plexiform Neurofibromas Following Positive Phase III KOMET Results
2025-11-20
Company data provided by crunchbase